Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Other experts too agreed that in Indias context, the new evidence raises important questions
Members may not know which formulary applies, and prescribers may not understand what criteria must be met, leading to frustrating back-and-forth between physician, patient, and insurer
Retrieved from Halford, J.C
By Drug Type, Liraglutide Segment Accounts for 35.5% Market Share The liraglutide segment is projected to account for 35.5% of the GLP-1 diabetes treatment drugs market in 2025, reaffirming its position as the leading drug type category
US$ 23.24
US$ 27.24
US$ 24.30
